Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Olaparib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in combination w/concurrent chemoradiation therapy followed by Pembrolizumab w/or w/o Olaparib compared w/concurrent chemoradiation therapy followed by Durvalumab in participants w/unresectable,Locally Advanced,STIII Non-Small Cell Lung Canc
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I